IP Library Granted Patent US 11,638,790
Granted Patent B2
US 11,638,790 · App. 16/989,560 · Granted May 2, 2023

Apparatus and methods for intravenous gas elimination

Inventors: Christopher Varga (Laguna Hills, CA); Jason Anthony Mohr (Fontana, CA); Megan Danielle Friedlander (San Diego, CA)
Assignee: VITAL SIGNS, INC.
A61M5/385A61M5/142A61M5/16813A61M5/16818A61M39/22A61M5/365A61M2205/3592A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,638,790
App. No.
16/989,560
Granted
May 2, 2023
Kind
B2
Abstract

A gas elimination apparatus and a method for use in an intravenous delivery system are provided. The apparatus includes a fluid inlet coupling a fluid flow into a liquid chamber, a fluid outlet protruding into the liquid chamber, and a flow diversion member proximal to the fluid outlet. The flow diversion member configured to block a direct flow between the fluid inlet and the fluid outlet. The apparatus includes a membrane separating a portion of the liquid chamber from an outer chamber and a gas venting valve fluidically coupling the outer chamber with the atmosphere. The flow diversion member may be mechanically supported by at least one strut or elongate member extending along a flow direction into the liquid chamber.

Claims (35)

1. An apparatus for use in an intravenous (IV) delivery system, comprising:

a fluid inlet coupling a fluid flow into a liquid chamber;

a fluid outlet protruding into the liquid chamber;

a flow diversion member proximal to the fluid outlet, the flow diversion member configured to block a direct flow between the fluid inlet and the fluid outlet;

a membrane comprising a wall concentrically disposed around the liquid chamber from the fluid inlet to the fluid outlet and separating the liquid chamber from an outer chamber, the membrane configured to allow a gas to pass from the liquid chamber to the outer chamber; and

a gas venting valve fluidically coupling the outer chamber with an atmosphere,

wherein the liquid chamber comprises a cylindrical shape with a longitudinal axis aligned with the fluid inlet and the fluid outlet, and wherein a cross section of the cylindrical shape is tapered up in one of a fluid outlet direction or a fluid inlet direction.

2. The apparatus of claim 1 , wherein the flow diversion member comprises an ellipsoidal shape longitudinally disposed along the flow direction.

3. The apparatus of claim 1 , wherein the flow diversion member comprises an umbrella shape having a convex portion disposed towards the fluid inlet.

4. The apparatus of claim 1 , wherein the flow diversion member comprises a conical shape having an apex disposed towards the fluid inlet.

5. The apparatus of claim 1 , wherein the flow diversion member comprises a pyramidal shape having an apex disposed towards the fluid inlet.

6. The apparatus of claim 1 , further comprising a strut connecting the flow diversion member to a support cage.

7. The apparatus of claim 6 , further comprising a support disposed at an end of the strut, wherein the support connects the strut to the support cage.

8. The apparatus of claim 1 , further comprising an end wall perpendicular to a longitudinal axis of the liquid chamber, the end wall configured to be impermeable to the fluid flow and to the gas.

9. The apparatus of claim 1 , further comprising an outer wall concentrically disposed around the outer chamber, the outer wall configured to be impermeable to the fluid flow and to the gas.

10. The apparatus of claim 9 , wherein the outer wall comprises a fence around the gas venting valve, the fence configured to prevent an external object from exerting pressure on the valve.

11. The apparatus of claim 1 , wherein the flow diversion member is mechanically supported by an elongate member extending along a flow direction into the liquid chamber.

12. The apparatus of claim 11 , wherein the elongate member is supported by one of the fluid inlet or the fluid outlet.

13. A system, comprising:

a container including an intravenous liquid;

a mechanism to provide a pressure to move the intravenous liquid through a fluid line to a patient; and

a gas elimination apparatus fluidically coupled with the fluid line, and configured to remove gas bubbles from the intravenous liquid, wherein the gas elimination apparatus comprises:

a fluid inlet coupling a fluid flow into a liquid chamber;

a fluid outlet protruding into the liquid chamber;

a flow diversion member proximal to the fluid outlet, the flow diversion member configured to block a direct flow between the fluid inlet and the fluid outlet;

a membrane comprising a wall concentrically disposed around the liquid chamber from the fluid inlet to the fluid outlet and separating the liquid chamber from an outer chamber, the membrane configured to allow a gas to pass from the liquid chamber to the outer chamber; and

a gas venting valve fluidically coupling the outer chamber with an atmosphere,

wherein the liquid chamber comprises a cylindrical shape with a longitudinal axis aligned with the fluid inlet and the fluid outlet, and wherein a cross section of the cylindrical shape is tapered up in one of a fluid outlet direction or a fluid inlet direction.

14. The system of claim 13 , further comprising a strut connecting the flow diversion member to a support cage.

15. The system of claim 14 , further comprising a support disposed at an end of the strut, wherein the support connects the strut to the support cage.

16. The system of claim 13 , wherein the flow diversion member in the gas elimination apparatus is selected from the group consisting of an ellipsoidal shape longitudinally disposed along the flow direction, an umbrella shape having a convex portion disposed towards the fluid inlet, a conical shape having an apex disposed towards the fluid inlet, and a pyramidal shape having an apex disposed towards the fluid inlet.

17. The system of claim 13 , further comprising an end wall perpendicular to a longitudinal axis of the liquid chamber, the end wall configured to be impermeable to the fluid flow and to the gas.

18. The system of claim 13 , further comprising an outer wall concentrically disposed around the outer chamber, the outer wall configured to be impermeable to the fluid flow and to the gas.

19. The system of claim 18 , wherein the outer wall comprises a fence around the gas venting valve, the fence configured to prevent an external object from exerting pressure on the valve.

20. The system of claim 13 , wherein the mechanism to provide a pressure comprises one of a pump, or a frame to place the container at a higher elevation relative to the patient.

Assignments (9)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Nov 25, 2024
From: MACQUARIE CAPITAL FUNDING LLC
To: MACQUARIE PF SERVICES LLC
Reel/Frame 069439/0549 →
SECURITY INTEREST Recorded Jun 29, 2023
From: VITAL SIGNS, INC.
To: MACQUARIE CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 064115/0528 →
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST RECORDED AT 060363/0460, 6/13/2022. Recorded May 3, 2023
From: BANK OF AMERICA, N.A.
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC.; VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063528/0973 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (060187/0171) Recorded May 2, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC. (AS SUCCESSOR IN INTEREST TO CAREFUSION 207, INC.); VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063516/0384 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (060363/0915) Recorded May 2, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC. (AS SUCCESSOR IN INTEREST TO CAREFUSION 207, INC.); VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063516/0067 →
SECURITY INTEREST Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC,
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 060187/0171 →
FIRST LIEN SECURITY AGREEMENT Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 060363/0460 →
PATENT SECURITY AGREEMENT (2ND LIEN) Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 060363/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2020
From: VARGA, CHRISTOPHER; MOHR, JASON ANTHONY; FRIEDLANDER, MEGAN DANIELLE
To: VITAL SIGNS, INC.
Reel/Frame 053456/0619 →